MICHAEL D. LOBERG - 31 Mar 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
31 Mar 2023
Transactions value $
$0
Form type
4
Filing time
04 Apr 2023, 18:57:07 UTC
Previous filing
04 Jan 2023
Next filing
06 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Gift $0 -533 -100% $0.00* 0 31 Jan 2023 Direct
transaction IGMS Common Stock Gift $0 +533 +1.49% $0.00 36.4K 31 Jan 2023 See footnote F1
transaction IGMS Common Stock Award $0 +1.14K $0.00 1.14K 31 Mar 2023 Direct F2
holding IGMS Common Stock 43.1K 31 Mar 2023 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Revocable Deed of Trust of Michael D. Loberg (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
F3 The shares are held by the Michael D. Loberg Qualified Annuity Interest Trust IX (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees.